Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
BMC Psychiatry|August 1, 2025
Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in SwedenNurgul Batyrbekova, Soo Aleman, Charlotte Lybeck, et al.
AIDS (London, England)|April 16, 2002
Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapySoo Aleman, Karin Söderbärg, Ubaldo Visco-Comandini, et al.
Hepatology Communications|August 26, 2022
ReplyAnn-Sofi Duberg, Charlotte Lybeck, Anna Fält, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2020
Frequent loss to follow-up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virusSoo Aleman, Jonas Söderholm, Katharina Büsch, et al.
Hepatology Communications|May 3, 2022
Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register studyAnn-Sofi Duberg, Charlotte Lybeck, Anna Fält, et al.
The International Journal on Drug Policy|May 4, 2024
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral eraCaroline Gahrton, Georg Navér, Anna Warnqvist, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 15, 2022
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptomsRebecca Folkman, Habiba Kamal, Marcus Ahl, et al.
Infectious Diseases (London, England)|March 3, 2018
Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017Martin Lagging, Rune Wejstål, Ann-Sofi Duberg, et al.
Biochemical and Biophysical Research Communications|March 5, 2013
Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patientsNogol Rahbin, Lars Frelin, Soo Aleman, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
BMC Psychiatry|August 1, 2025
Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in SwedenNurgul Batyrbekova, Soo Aleman, Charlotte Lybeck, et al.
AIDS (London, England)|April 16, 2002
Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapySoo Aleman, Karin Söderbärg, Ubaldo Visco-Comandini, et al.
Hepatology Communications|August 26, 2022
ReplyAnn-Sofi Duberg, Charlotte Lybeck, Anna Fält, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2020
Frequent loss to follow-up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virusSoo Aleman, Jonas Söderholm, Katharina Büsch, et al.
Hepatology Communications|May 3, 2022
Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register studyAnn-Sofi Duberg, Charlotte Lybeck, Anna Fält, et al.
The International Journal on Drug Policy|May 4, 2024
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral eraCaroline Gahrton, Georg Navér, Anna Warnqvist, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 15, 2022
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptomsRebecca Folkman, Habiba Kamal, Marcus Ahl, et al.
Infectious Diseases (London, England)|March 3, 2018
Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017Martin Lagging, Rune Wejstål, Ann-Sofi Duberg, et al.
Biochemical and Biophysical Research Communications|March 5, 2013
Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patientsNogol Rahbin, Lars Frelin, Soo Aleman, et al.
Pageof 15